Steroid Avoidance With Low-Dose Tacrolimus is Safe and Effective in the Long-Term for Kidney Transplant Recipients
SA proved to be safe and effective in patients with low immunological risk for up to 7 years following kidney transplantation. Our findings provide robust evidence supporting SA strategy with low-dose tacrolimus without compromising outcomes even at the extended 7-years follow up.
Authors
- Per Lindnér (ORCID: https://orcid.org/0000-0001-8672-6811)
- Jana Ekberg (ORCID: https://orcid.org/0000-0002-0650-538X)
- Seema Baid‐Agrawal (ORCID: https://orcid.org/0000-0001-8192-1079)
- Carin Wallquist (ORCID: https://orcid.org/0000-0001-7063-2925)
- Karin Skov (ORCID: https://orcid.org/0000-0003-1559-4836)
- Anna-Elisabeth Aagaard Enevoldsen
- Bente Jespersen (ORCID: https://orcid.org/0000-0001-7196-2870)
Institutions
- Aarhus University Hospital (DK)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1016/j.ekir.2025.06.016
- Citations
- 1
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.99
Funders
- Aarhus Universitetshospital